ABSTRACT
This article reviews the current legislative requirements for risk assessment of combined exposure to multiple chemicals via multiple exposure routes, focusing on human health and particularly on food-related chemicals. The aim is to identify regulatory needs and current approaches for this type of risk assessment as well as challenges of the implementation of appropriate and harmonized guidance at international level. It provides an overview of the current legal requirements in the European Union (EU), the United States and Canada. Substantial differences were identified in the legal requirements for risk assessment of combined exposure to multiple chemicals and its implementation between EU and non-EU countries and across several regulatory sectors. Frameworks currently proposed and in use for assessing risks from combined exposure to multiple chemicals via multiple routes and different durations of exposure are summarized. In order to avoid significant discrepancies between regulatory sectors or countries, the approach for assessing risks of combined exposure should be based on similar principles for all types of chemicals. OECD and EFSA identified the development of harmonized methodologies for combined exposure to multiple chemicals as a key priority area. The Horizon 2020 project "EuroMix" aims to contribute to the further development of internationally harmonized approaches for such risk assessments by the development of an integrated test strategy using in vitro and in silico tests verified for chemical mixtures based on more appropriate data on potential combined effects. These approaches and testing strategies should be integrated in a scientifically based weight of evidence approach to account for complexity and uncertainty, to improve risk assessment.
Subject(s)
Environmental Exposure/legislation & jurisprudence , Environmental Policy/legislation & jurisprudence , Environmental Pollutants , Risk Assessment/methods , Environmental Exposure/standards , European Union , HumansABSTRACT
This study aims to evaluate the evidence for the existence of non-monotonic dose-responses (NMDRs) of substances in the area of food safety. This review was performed following the systematic review methodology with the aim to identify in vivo studies published between January 2002 and February 2015 containing evidence for potential NMDRs. Inclusion and reliability criteria were defined and used to select relevant and reliable studies. A set of six checkpoints was developed to establish the likelihood that the data retrieved contained evidence for NMDR. In this review, 49 in vivo studies were identified as relevant and reliable, of which 42 were used for dose-response analysis. These studies contained 179 in vivo dose-response datasets with at least five dose groups (and a control group) as fewer doses cannot provide evidence for NMDR. These datasets were extracted and analyzed using the PROAST software package. The resulting dose-response relationships were evaluated for possible evidence of NMDRs by applying the six checkpoints. In total, 10 out of the 179 in vivo datasets fulfilled all six checkpoints. While these datasets could be considered as providing evidence for NMDR, replicated studies would still be needed to check if the results can be reproduced to rule out that the non-monotonicity was caused by incidental anomalies in that specific study. This approach, combining a systematic review with a set of checkpoints, is new and appears useful for future evaluations of the dose response datasets regarding evidence of non-monotonicity.
Subject(s)
Databases, Factual/statistics & numerical data , Food Safety/methods , Statistics as Topic/methods , Animals , Dose-Response Relationship, Drug , HumansABSTRACT
Studies of GR-interacting proteins can provide valuable insights into the regulation of GR cellular signalling. The cytoplasmic localization of GR and reports of GR interaction with such a plethora of other cytoplasmic proteins may point to a unique role for GR in modulating and integrating other signalling pathways. A better insight into these interactions could serve as a tool when trying to understand and modify GR signalling.
Subject(s)
Cytosol/metabolism , Receptors, Glucocorticoid/metabolism , 14-3-3 Proteins , Cytoskeletal Proteins/metabolism , Humans , Molecular Chaperones/metabolism , NF-kappa B/metabolism , Protein Binding , Proto-Oncogene Proteins c-raf/metabolism , Tyrosine 3-Monooxygenase/metabolismABSTRACT
Proteins belonging to the 14--3-3 family interact with various regulatory proteins involved in cellular signaling, cell cycle regulation, or apoptosis. 14--3-3 proteins have been suggested to act by regulating the cytoplasmic/nuclear localization of their target proteins or by acting as molecular scaffolds or chaperones. We have previously shown that overexpression of 14--3-3 enhances the transcriptional activity of the glucocorticoid receptor (GR), which is a member of the nuclear receptor family. In this study, we show that 14--3-3 interacts with the nuclear receptor corepressor RIP140. In transfection assays, RIP140 antagonizes 14--3-3- enhanced GR transactivation. Using colocalization studies we demonstrate that 14--3-3 can export RIP140 out of the nucleus and, interestingly, can also change its intranuclear localization. Moreover, we also observed that 14--3-3 can bind various other nuclear receptors and cofactors. In summary, our findings suggest that 14--3-3-mediated intracellular relocalization of the GR corepressor RIP140 might be a novel mechanism to enhance glucocorticoid responsiveness of target genes. They furthermore indicate a more general role for 14--3-3 protein by influencing the nuclear availability of nuclear receptor-associated cofactors.
Subject(s)
Nuclear Proteins/metabolism , Receptors, Glucocorticoid/metabolism , Repressor Proteins/metabolism , Tyrosine 3-Monooxygenase/metabolism , 14-3-3 Proteins , Adaptor Proteins, Signal Transducing , Animals , COS Cells , Cell Nucleus/metabolism , Cytoplasm/metabolism , Nuclear Proteins/genetics , Nuclear Receptor Interacting Protein 1 , Phosphorylation , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Receptors, Glucocorticoid/genetics , Receptors, Retinoic Acid/genetics , Receptors, Retinoic Acid/metabolism , Repressor Proteins/genetics , Retinoid X Receptors , Subcellular Fractions , Transcription Factors/genetics , Transcription Factors/metabolism , Transcriptional Activation , Tyrosine 3-Monooxygenase/geneticsABSTRACT
The glucocorticoid receptor (GR) functions as a ligand-dependent transcription factor. In the present study we describe a specific immunoaffinity chromatography purification of GR from liver cytosol from adrenalectomized rats that may be used to identify hitherto unknown cytosolic GR interacting proteins. We have identified the ubiquitously expressed 14-3-3 as well as Raf-1, a downstream effector of Ras, as GR co-purifying proteins. In our semi-quantitative analysis liganded/activated GR showed the strongest interaction with 14-3-3 and Raf-1, but 14-3-3 was also found to co-purify with GR in a nonliganded/nonactivated state. By extensive salt washes we were also able to demonstrate that the glucocorticoid induced interaction between GR, 14-3-3, and Raf-1, respectively, is remarkably stable and withstood 2.4 m salt. The interaction between GR and 14-3-3 was also verified by 14-3-3 co-immunoprecipitation studies. Our observations that GR and Raf-1 are found within the same protein complex ("receptosome") in the cytoplasm of rat liver cells could provide a mechanistic explanation for glucocorticoid effects on the Raf-1-Ras signaling pathway.
Subject(s)
Proto-Oncogene Proteins c-raf/metabolism , Receptors, Glucocorticoid/metabolism , Signal Transduction , Tyrosine 3-Monooxygenase/metabolism , 14-3-3 Proteins , Animals , Blotting, Western , Chromatography, Affinity , Cytoplasm/metabolism , Cytosol/metabolism , Electrophoresis, Polyacrylamide Gel , Female , Ligands , Liver/metabolism , Precipitin Tests , Protein Binding , Proto-Oncogene Proteins c-raf/isolation & purification , Rats , Receptors, Glucocorticoid/isolation & purification , Sodium Chloride/pharmacology , Tyrosine 3-Monooxygenase/isolation & purificationABSTRACT
Mizoribine (MIZ) is a novel imidazole nucleoside with immunosuppressive activity. MIZ has been approved in Japan and combination therapy with MIZ and glucocorticoids has been used after renal transplantation and for lupus nephritis and rheumatoid arthritis. In this study, we identify 14-3-3 proteins as MIZ-binding proteins. 14-3-3 proteins interact with many proteins involved in cellular signaling, including the glucocorticoid receptor (GR). The 14-3-3/GR interaction enhances the transcriptional activity of the receptor. We show that MIZ affects the conformation of 14-3-3 proteins and enhances the interaction of GR and 14-3-3eta dose dependently in vitro. MIZ also has a stimulatory effect on transcriptional activation by the GR. Our results point to the possibility that one mechanism for the therapeutic effect of MIZ could be to regulate the GR function via 14-3-3 proteins.
Subject(s)
Immunosuppressive Agents/pharmacology , Proteins/metabolism , Ribonucleosides/pharmacology , Tyrosine 3-Monooxygenase , 14-3-3 Proteins , Animals , COS Cells , Circular Dichroism , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Glutathione Transferase/metabolism , Immunosuppressive Agents/chemistry , Kidney/chemistry , Protein Binding , Protein Conformation , Proteins/chemistry , Receptors, Glucocorticoid/metabolism , Ribonucleosides/chemistry , Signal Transduction , Spectrophotometry , Swine , Transcriptional Activation , TransfectionABSTRACT
The yeast two-hybrid system was used to isolate cDNAs encoding proteins that interact with the glucocorticoid receptor (GR) ligand-binding domain in a ligand-dependent manner. One isolated cDNA encoded a fragment of death-associated protein 3 (DAP3), which has been implicated as a positive mediator of apoptosis. In vitro experiments showed that the full-length DAP3 also interacted with GR. The main interaction domain was mapped to the N-terminal region of DAP3 that had previously been shown to function in a dominant-negative fashion, protecting cells from apoptosis. Co-transfection experiments in COS-7 cells showed that DAP3 had a stimulatory effect on the ligand-induced transcriptional activation by GR and also increased the steroid-sensitivity. Furthermore, DAP3 formed a complex with several other nuclear receptors and some basic helix-loop-helix/Per-Arnt-Sim proteins, as well as with heat-shock protein 90 (hsp90) (Arnt is the aryl-hydrocarbon-receptor nuclear translocator, and Per and Sim are the Drosophila proteins Period and Single-minded). The results suggest that DAP3 could have an important role in GR action, possibly by modulating the cytoplasmic GR-hsp90 complex. Since glucocorticoids can induce apoptosis, the pro-apoptotic DAP3 protein may be involved in this function of GR.
Subject(s)
Proteins/metabolism , Receptors, Glucocorticoid/metabolism , Amino Acid Sequence , Animals , Apoptosis , Apoptosis Regulatory Proteins , Binding Sites , COS Cells , Dimerization , Protein Binding , Proteins/chemistry , RNA-Binding Proteins , Receptors, Glucocorticoid/physiology , Ribosomal Proteins , Transcription, Genetic , Two-Hybrid System TechniquesABSTRACT
The glucocorticoid receptor (GR) regulates target gene expression in response to corticosteroid hormones. We have investigated the mechanism of transcriptional activation by the GR by studying the role of the receptor interacting protein RIP140. Both in vivo and in vitro protein-protein interaction assays revealed a ligand-dependent interaction between the GR and RIP140. The ligand binding domain of the GR was sufficient for this interaction, while both the N- and C-terminal regions of RIP140 bound to the receptor. In a yeast transactivation assay RIP140 and SRC-1, a member of the steroid receptor coactivator family of proteins, both enhanced the transactivation activity of a GR protein (GRA-1) in which the potent N-terminal tau1 transactivation domain has been deleted. In contrast, in COS-7 cells increasing amounts of RIP140 significantly inhibited GRdeltatau1 function. In cotransfection studies in COS-7 cells, RIP140 also inhibited receptor activity in presence of both SRC-1 and the coactivator protein CBP together. Thus, in yeast cells a stimulation of receptor activity was observed, while in mammalian cells RIP140 repressed GR function. Taken together, these data suggest that, (1) RIP140 is a target protein for the GR and (2) RIP140 can modulate the transactivation activity of the receptor.
Subject(s)
Nuclear Proteins/metabolism , Receptors, Glucocorticoid/metabolism , Transcriptional Activation , Adaptor Proteins, Signal Transducing , Animals , Binding Sites , COS Cells , CREB-Binding Protein , Histone Acetyltransferases , Humans , In Vitro Techniques , Ligands , Nuclear Proteins/genetics , Nuclear Receptor Coactivator 1 , Nuclear Receptor Interacting Protein 1 , Protein Binding , Receptors, Glucocorticoid/genetics , Receptors, Steroid/genetics , Receptors, Steroid/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , TransfectionABSTRACT
The glucocorticoid receptor (GR) is a ligand-activated transcription factor. In this study, we used the yeast two-hybrid system to isolate cDNAs encoding proteins that interact with the human GR ligand-binding domain (LBD) in a ligand-dependent manner. One isolated cDNA from a HeLa cell library encoded the COOH-terminal portion of the eta-isoform of the 14-3-3 protein (residues 187-246). Glucocorticoid agonists, triamcinolone acetonide and dexamethasone, induced the GR LBD/14-3-3eta protein fragment interaction, but an antagonist, RU486, did not. Glutathione S-transferase pull-down experiments in vitro showed that full-length 14-3-3eta protein also interacted with the activated GR. Transient transfection studies using COS-7 cells revealed a stimulatory effect of 14-3-3eta protein on transcriptional activation by the GR. The 14-3-3 family members have recently been found to associate with a number of important signaling proteins, such as protein kinase C and Raf-1, as functional modulators. Our findings suggest a novel regulatory role of 14-3-3eta protein in GR-mediated signaling pathways and also point to a mechanism whereby GR may cross-talk with other signal transduction systems.
Subject(s)
Enzyme Inhibitors/metabolism , Phospholipases A/antagonists & inhibitors , Phosphopyruvate Hydratase/antagonists & inhibitors , Protein Kinase C/antagonists & inhibitors , Proteins/metabolism , Receptors, Glucocorticoid/metabolism , Tyrosine 3-Monooxygenase , 14-3-3 Proteins , Calcium/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , DNA, Complementary/chemistry , HeLa Cells , Humans , Protein Conformation , Proteins/genetics , Signal TransductionSubject(s)
DNA-Binding Proteins/metabolism , DNA/metabolism , Receptors, Steroid/metabolism , Amino Acid Sequence , Animals , Base Composition , Base Sequence , Consensus Sequence , DNA/chemistry , DNA-Binding Proteins/chemistry , Humans , Molecular Sequence Data , Nucleic Acid Conformation , Protein Binding , Protein Conformation , Rats , Receptors, Steroid/chemistry , Regulatory Sequences, Nucleic Acid , Structure-Activity Relationship , Substrate Specificity , Transcription, GeneticABSTRACT
Regulation of gene expression involves a large number of transcription factors with unique DNA-binding properties. Many transcription factors belong to families of related proteins that bind to similar but distinct sequences. In this study we have analyzed how amino acid substitutions at a single position in the DNA-binding domain modulate the DNA-binding specificity within the nuclear receptor family of transcription factors. All possible amino acids were introduced at the first position in the DNA recognition helix, and the specificities of the mutants were analyzed using response elements containing all combinations of bases at two variable base pair positions. All mutant proteins were functional in DNA binding, and could be divided into classes of mutants with different response element specificities. By combining functional data with analysis of the structural effects of the mutations by molecular modeling, we could identify both prohibitive steric interactions as well as positive interactions, such as hydrogen bonds, that function as important determinants for specificity. Only the residues found naturally in the glucocorticoid and estrogen receptors, glycine and glutamate, produce unique binding specificities. The specificities of the other mutants overlap with each other somewhat but the substitutions clearly have potential to contribute to diversity within the nuclear receptor family.
Subject(s)
DNA-Binding Proteins/chemistry , DNA/chemistry , Receptors, Cytoplasmic and Nuclear/chemistry , Amino Acid Sequence , Amino Acids/chemistry , Animals , Base Sequence , Binding Sites , DNA/metabolism , Humans , Models, Molecular , Molecular Sequence Data , Receptors, Cytoplasmic and Nuclear/metabolism , Yeasts/chemistry , Yeasts/metabolismABSTRACT
Nuclear receptors are ligand-activated transcription factors that interact with response elements within regulated genes. Most receptors, typified by the estrogen receptor, have three amino acids within the DNA-binding domain that specify recognition of the sequence TGACCT within the response element. However, in the glucocorticoid group of receptors, these residues have evolved to recognize the sequence TGTTCT. Saturation mutagenesis was used to investigate the role played by two of these residues (Gly-439 and Ser-440 of the human glucocorticoid receptor) in receptor specificity. We conclude that these residues, and their equivalents in the estrogen receptor, play roles unique to the respective amino acids. In the glucocorticoid receptor the side chain hydroxyl group is the important component of Ser-440 that contributes to specificity by inhibiting interaction with estrogen response elements. Several substitution mutants at position 439 interact well with estrogen response elements; therefore, the unique specificity feature of Glu-439, which mimics the estrogen receptor, is its inhibition of interaction with noncognate sites. In contrast to position 440, where most substitutions prevent interaction with DNA, replacements of residue 439 have the potential to contribute to the evolution of DNA-binding specificities within the nuclear receptor family. The liver-enriched HNF-4 and Drosophila Tailless transcription factors are known examples of receptors that have diverged at this position.
Subject(s)
Biological Evolution , DNA-Binding Proteins/genetics , DNA/chemistry , DNA/metabolism , Phosphoproteins , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Glucocorticoid/genetics , Transcription Factors/genetics , Transcription Factors/metabolism , Amino Acid Sequence , Animals , Base Sequence , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/metabolism , Drosophila , Hepatocyte Nuclear Factor 4 , Humans , Liver/metabolism , Molecular Sequence Data , Mutagenesis, Insertional , Protein Conformation , Receptors, Cytoplasmic and Nuclear/chemistry , Receptors, Cytoplasmic and Nuclear/metabolism , Saccharomyces cerevisiae/metabolism , Substrate Specificity , Transcription Factors/chemistry , Transcriptional Activation , Zinc Fingers/geneticsABSTRACT
The thermodynamics of sequence-specific DNA-protein interactions provide a complement to structural studies when trying to understand the molecular basis for sequence specificity. We have used fluorescence spectroscopy to study the chemical equilibrium between the wild-type and a triple mutant glucocorticoid receptor DNA-binding domain (GR DBD wt and GR DBDEGA, respectively) and four related DNA-binding sites (response elements). NMR spectroscopy was used to confirm that the structure of the two proteins is very similar in the uncomplexed state. Binding to DNA oligomers containing single half-sites and palindromic binding sites was studied to obtain separate determinations of association constants and cooperativity parameters involved in the dimeric DNA binding. Equilibrium parameters were determined at 10-35 degrees C in 85 mM NaCl, 100 mM KCl, 2 mM MgCl2, and 20 mM Tris-HCl at pH 7.4 (20 degrees C) and at low concentrations of an antioxidant and a nonionic detergent. GR DBDwt binds preferentially to a palindromic consensus glucocorticoid response element (GRE) with an association constant of (7.6 +/- 0.9) x 10(5) M-1 and a cooperativity parameter of 10 +/- 1 at 20 degrees C. GR DBDEGA has the highest affinity for an estrogen response element (ERE) with an association constant of (2.2 +/- 0.3) x 10(5) M-1 and a cooperativity parameter of 121 +/- 17 at 20 degrees C. The difference in cooperativity in the two binding processes, which indicates significant differences in binding modes, was confirmed using gel mobility assays. van't Hoff analysis shows that DNA binding in all cases in entropy driven within the investigated temperature range. We find that delta H0obs and delta S0obs for the formation of a GR DBDwt-GRE versus GR DBDEGA-ERE complex are significantly different despite very similar delta G0obs values. A comparison of GR DBDwt binding to two similar GREs reveals that the discrimination between these two (specific) sites is due to a favorable delta(delta S0obs) which overcompensates an unfavorable delta(delta H0obs), i.e., the sequence specificity is in this case entropy driven. Thus, entropic effects are of decisive importance for the affinity as well as the specificity in GR-DNA interactions. The molecular basis for measured equilibrium and thermodynamic parameters is discussed on the basis of published structures of GR DBD-GRE and ER DBD-ERE complexes.
Subject(s)
DNA-Binding Proteins/chemistry , DNA/chemistry , Receptors, Glucocorticoid/chemistry , Amino Acid Sequence , Animals , Base Sequence , DNA/metabolism , DNA-Binding Proteins/metabolism , Humans , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Rats , Receptors, Glucocorticoid/metabolism , Regulatory Sequences, Nucleic Acid , ThermodynamicsABSTRACT
Glucocorticoids cause changes in the expression of target genes via interaction with an intracellular receptor protein, the glucocorticoid receptor. This signal transduction process can be divided into a number of steps, each of which represents a functional facet of the receptor protein. These steps include (i) receptor transformation to an active form resulting from specific interaction with glucocorticoid steroid hormones, (ii) homo-dimerization, (iii) DNA-binding to specific hormone response elements in the genome and (iv) modulation of the expression levels of linked genes. These aspects of glucocorticoid receptor function have been studied using a combination of tertiary structure determination, biochemical assays and a genetic approach using a yeast system to screen for mutant receptors that are altered in function. The results show that contacts involving both the DNA and steroid binding domains are involved in dimerization and high affinity DNA binding. Genetic experiments have illuminated the role of amino acids within the recognition helix of the DNA-binding domain in discriminating between cognate DNA response elements for the glucocorticoid receptor and closely related binding sites for other nuclear receptors. Squelching experiments suggest that the N-terminal transactivation domain of the receptor contacts components of the general transcriptional machinery that appear to be distinct from the TATA binding protein, TFIID, during transactivation of gene expression by the DNA-bound receptor.
Subject(s)
Receptors, Glucocorticoid/chemistry , Receptors, Glucocorticoid/physiology , Amino Acid Sequence , Base Sequence , Binding Sites , DNA/metabolism , Glucocorticoids/pharmacology , Macromolecular Substances , Molecular Sequence Data , Saccharomyces cerevisiae , Signal Transduction/drug effectsABSTRACT
The glucocorticoid receptor binds with high specificity to glucocorticoid response elements, discriminating them from other closely related binding sites. Three amino acids in the recognition alpha-helix of the DNA-binding domain of the receptor are primarily responsible for this specific DNA binding activity. In this study we analyze in detail how these residues determine the specific DNA binding by studying a series of mutant glucocorticoid receptor DNA-binding domains containing all combinations of glucocorticoid and estrogen receptor-specific residues at these positions. Statistical analysis of the results enables us to create models describing the association between amino acids and base pairs. Several strategies appear to be used in accomplishing discrimination between the glucocorticoid and estrogen response elements. Single residues (i.e., Val-443 in the glucocorticoid receptor and Glu-439 in the estrogen receptor) appear to form both positive contacts with specific base pairs in the cognate binding site and negative contacts in the non-cognate site. In the glucocorticoid receptor Ser-440 is pleiotropically negative for all sites tested but the negative effect is stronger for the estrogen response element thus contributing to binding site discrimination. Furthermore, combinations of amino acids appear to act synergistically, most often causing a reduction in binding to non-cognate sites.
Subject(s)
DNA-Binding Proteins/metabolism , DNA/metabolism , Receptors, Glucocorticoid/metabolism , Amino Acid Sequence , Base Composition , Base Sequence , Binding Sites , Cloning, Molecular , DNA/genetics , Escherichia coli/genetics , Humans , Kinetics , Models, Statistical , Molecular Sequence Data , Mutagenesis, Site-Directed , Nucleic Acid Conformation , Plasmids , Polymerase Chain Reaction , Protein Conformation , Receptors, Glucocorticoid/genetics , Recombinant Proteins/metabolismABSTRACT
The DNA-binding domain of the glucocorticoid receptor contains two zinc ions which are important for the structure and function of the protein. The zinc ions are tetrahedrally coordinated by cysteine residues within the DNA-binding domain. The DNA-binding domain of the glucocorticoid receptor, as well as of the other nuclear hormone receptors, contains nine highly conserved cysteine residues. It has not been clearly established which of these nine cysteine residues are involved in the coordination of zinc. Two models have been proposed for the zinc coordination scheme. We present evidence in favour of the model which excludes the most C-terminal cysteine residue (Cys-481 of the human glucocorticoid receptor) from the zinc coordination scheme. Mutation of this residue in the context of the glucocorticoid receptor DNA-binding domain expressed in E. coli does not significantly reduce the structural integrity of the protein or its DNA-binding properties. These in vitro results are also confirmed by in vivo transactivation assays in yeast.
Subject(s)
DNA-Binding Proteins/metabolism , Receptors, Glucocorticoid/metabolism , Zinc/metabolism , Amino Acid Sequence , Base Sequence , Binding Sites , Cations, Divalent , Electrophoresis, Polyacrylamide Gel , Escherichia coli/genetics , Humans , Molecular Sequence Data , Mutagenesis, Site-Directed , Receptors, Glucocorticoid/genetics , Transcriptional ActivationABSTRACT
Mutation of a small number of amino acids in the DNA-binding domain of the estrogen receptor to the corresponding sequence of the glucocorticoid receptor switches the specificity of the receptor in transactivation assays (Mader, S., Kumar, V., de Verneuil, H., and Chambon, P. (1989) Nature 338, 271-274). We have made the corresponding reciprocal mutations in the context of the glucocorticoid receptor DNA-binding domain and studied the binding of wild type and mutant purified proteins to palindromic glucocorticoid and estrogen response elements as well as to elements of intermediate sequence, using gel mobility shift assays. We show here that a protein with two altered amino acids binds glucocorticoid and estrogen response elements with a low but equal affinity, whereas a protein with an additional changed residue has a high affinity for estrogen response elements but still retains a considerable affinity for glucocorticoid response elements. Using binding sites of intermediate sequence we have further characterized the interaction with DNA. The in vitro DNA binding results are confirmed by in vivo transactivation assays in yeast. Finally we suggest a testable model for amino acid/base pair interactions involved in recognition by the glucocorticoid receptor DNA-binding domain of its target sequence.